Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective
Open Access
- 24 July 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (15), 5291
- https://doi.org/10.3390/ijms21155291
Abstract
Arginase is a widely known enzyme of the urea cycle that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of hepatic ureogenic function, being widespread through most tissues. Two arginase isoforms coexist, the type I (Arg1) predominantly expressed in the liver and the type II (Arg2) expressed throughout extrahepatic tissues. By producing L-ornithine while competing with nitric oxide synthase (NOS) for the same substrate (L-arginine), arginase can influence the endogenous levels of polyamines, proline, and NO•. Several pathophysiological processes may deregulate arginase/NOS balance, disturbing the homeostasis and functionality of the organism. Upregulated arginase expression is associated with several pathological processes that can range from cardiovascular, immune-mediated, and tumorigenic conditions to neurodegenerative disorders. Thus, arginase is a potential biomarker of disease progression and severity and has recently been the subject of research studies regarding the therapeutic efficacy of arginase inhibitors. This review gives a comprehensive overview of the pathophysiological role of arginase and the current state of development of arginase inhibitors, discussing the potential of arginase as a molecular imaging biomarker and stimulating the development of novel specific and high-affinity arginase imaging probes.This publication has 244 references indexed in Scilit:
- Arginase II inhibitory activity of flavonoid compounds from Scutellaria indicaArchives of Pharmacal Research, 2013
- Korean red ginseng inhibits arginase and contributes to endothelium-dependent vasorelaxation through endothelial nitric oxide synthase couplingJournal of Ginseng Research, 2013
- Role of Arginase in Vessel Wall RemodelingFrontiers in Immunology, 2013
- Inhibition of human arginase I by substrate and product analoguesArchives of Biochemistry and Biophysics, 2010
- Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscopeCytotechnology, 2009
- iNOS expression requires NADPH oxidase‐dependent redox signaling in microvascular endothelial cellsJournal of Cellular Physiology, 2008
- Evolution of the arginase fold and functional diversityCellular and Molecular Life Sciences, 2008
- Expression, purification, assay, and crystal structure of perdeuterated human arginase IArchives of Biochemistry and Biophysics, 2007
- Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted miceCardiovascular Research, 2007
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004